Krensky A M, Sanchez-Madrid F, Robbins E, Nagy J A, Springer T A, Burakoff S J
J Immunol. 1983 Aug;131(2):611-6.
Three cell surface antigens associated with the cytolytic T lymphocyte(CTL)-target cell interaction were identified by generation of monoclonal antibodies (MAb) against OKT4+, HLA-DR-specific CTL and selection for inhibition of cytolysis in a 51Cr-release assay. These MAb block cytolysis by both OKT4+ and OKT8+ CTL and the proliferative responses to PHA and the mixed lymphocyte response (MLR). LFA-1 is an antigen widely distributed on lymphoid tissues and is composed of two polypeptides of 177,000 and 95,000 Mr on all cell types studied. Anti-LFA-1 MAb block NK cell-mediated cytolysis in addition to T lymphocyte-mediated cytotoxicity and proliferation. LFA-2 (Mr = 55,000 to 47,000), a determinant on the sheep red blood cell receptor, is expressed by T cells but not B cells and appears specific for T cell functions. LFA-3 (Mr = 60,000) is a widely distributed antigen present on both hematopoietic and nonhematopoietic tissues and appears to only be involved in T cell functions. MAb to LFA-1 and LFA-2 inhibit function by binding to effector cell surface molecules, whereas anti-LFA-3 MAb appear to block by binding to the target cells. Together with previously described molecules, LFA-1, LFA-2, and LFA-3 demonstrate the complexity of CTL-mediated cytotoxicity at the molecular level.
通过制备针对OKT4 +、HLA - DR特异性细胞毒性T淋巴细胞(CTL)的单克隆抗体(MAb),并在51Cr释放试验中筛选抑制细胞溶解的抗体,鉴定出三种与CTL - 靶细胞相互作用相关的细胞表面抗原。这些MAb可阻断OKT4 +和OKT8 + CTL介导的细胞溶解以及对PHA的增殖反应和混合淋巴细胞反应(MLR)。淋巴细胞功能相关抗原-1(LFA - 1)是一种广泛分布于淋巴组织的抗原,在所研究的所有细胞类型上由两条分子量分别为177,000和95,000的多肽组成。抗LFA - 1 MAb除了阻断T淋巴细胞介导的细胞毒性和增殖外,还可阻断自然杀伤(NK)细胞介导的细胞溶解。淋巴细胞功能相关抗原-2(LFA - 2,分子量= 55,000至47,000)是绵羊红细胞受体上的一个决定簇,由T细胞表达而B细胞不表达,似乎对T细胞功能具有特异性。淋巴细胞功能相关抗原-3(LFA - 3,分子量= 60,000)是一种广泛分布于造血和非造血组织的抗原,似乎仅参与T细胞功能。抗LFA - 1和LFA - 2的MAb通过与效应细胞表面分子结合来抑制功能,而抗LFA - 3 MAb似乎通过与靶细胞结合来阻断。与先前描述的分子一起,LFA - 1、LFA - 2和LFA - 3在分子水平上证明了CTL介导的细胞毒性的复杂性。